Tourette's disorder

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
3 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 3 Phase II: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

3 trials
  • Emalex Biosciences Inc. Commercial
    ECOPIPAM HYDROCHLORIDE
    2023-503494-38-00 9 countries 2023 n=99
    Ended
  • Emalex Biosciences Inc. Commercial
    ECOPIPAM HYDROCHLORIDE
    2023-503545-67-00 8 countries 2024 n=38
    Recruiting
  • Emalex Biosciences Inc. Academic
    ECOPIPAM HYDROCHLORIDE
    2023-503494-38-00 9 countries 2023 n=99
    Ended

Phase II

1 trial
  • Noema Pharma AG Commercial
    GEMLAPODECT
    2023-505086-83-00 6 countries 2024 n=130
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Emalex Biosciences Inc. Commercial 3 Phase III 1
Noema Pharma AG Commercial 1 Phase II 0
New trials by year
2023
2
2024
2
← All indication landscapes